0001181431-13-040447.txt : 20130717
0001181431-13-040447.hdr.sgml : 20130717
20130717211307
ACCESSION NUMBER: 0001181431-13-040447
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130717
FILED AS OF DATE: 20130717
DATE AS OF CHANGE: 20130717
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VERTICAL GROUP LP
CENTRAL INDEX KEY: 0001180179
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 13973783
BUSINESS ADDRESS:
STREET 1: 25 DEFOREST AVE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: 9082773737
MAIL ADDRESS:
STREET 1: 25 DEFOREST AVE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
3
1
rrd385856.xml
X0206
3
2013-07-17
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001180179
VERTICAL GROUP LP
25 DEFOREST AVE
SUMMIT
NJ
07901
0
0
1
0
Series A Preferred Stock
0
Class A Common Stock
473122
I
See Footnote
Series A Preferred Stock
0
Class A Common Stock
237403
I
See Footnote
Series B Preferred Stock
0
Class A Common Stock
547205
I
See Footnote
Series B Preferred Stock
0
Class A Common Stock
287527
I
See Footnote
Series B-1 Preferred Stock
0
Class A Common Stock
666661
I
See Footnote
Series B-1 Preferred Stock
0
Class A Common Stock
278764
I
See Footnote
Each share of Series A, Series B and Series B-1 Preferred Stock will automatically convert on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering.
The securities are immediately convertible.
The expiration date is not relevant to the conversion of these securities.
The Class A Common Stock will be redesignated "Common Stock" immediately prior to the consummation of the Issuer's initial public offering.
The shares are held directly by Vertical Fund I, L.P., ("VFI"), a Delaware limited partnership. The Vertical Group, L.P. ("VG LP"), a Delaware limited partnership, is the sole general partner of VFI, and The Vertical Group GP, LLC ("VG LLC"), a Delaware limited liability company, controls VG LP. VG LP and VG LLC disclaim beneficial ownership of all securities that may be deemed to be beneficially owned by VFI except to the extent of any pecuniary interest therein. This Form 3 shall not be deemed an admission that VG LP, VG LLC or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
The shares are held directly by Vertical Fund II, L.P., ("VFII"), a Delaware limited partnership. The Vertical Group, L.P. ("VG LP"), a Delaware limited partnership, is the sole general partner of VFII, and The Vertical Group GP, LLC ("VG LLC"), a Delaware limited liability company, controls VG LP. VG LP and VG LLC disclaim beneficial ownership of all securities that may be deemed to be beneficially owned by VFII except to the extent of any pecuniary interest therein. This Form 3 shall not be deemed an admission that VG LP, VG LLC or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
/s/ John E. Runnells, Authorized Signatory for The Vertical Group, L.P.
2013-07-17